How A.I. Is Disrupting Pharma: The High-Stakes Race to Revolutionize Drug Discovery
A.I. is shaking up how new drugs get made. Companies like Immunai and AstraZeneca are using A.I. to make clinical trials faster and more precise. That means finding the right treatments more quickly, but it also raises concerns about control over who benefits. The FDA now wants to regulate this process to ensure safety.